17-05-2018, 11:43 PM
(This post was last modified: 15-07-2020, 12:29 AM by dreamybear.)
Thanks karlmarx, for the insightful write-up on Hyphens Pharma International Limited(HYP).
According to BT article today, it was 152 times subscribed ! (Ref : https://www.businesstimes.com.sg/compani...subscribed)
I applied quite last minute but wasn't allocated any. For me, I feel HYP is selling "ëstablished products", i.e. the pdts are already on the market for some time, and there is a certain demand for them(e.g. eczema is a common condition) . Furthermore, it is also a net cash company.
You are right to point out the questions on its competitive advantage, for e.g. I don't think its skin care pdts are the most popular ones(compared to the Curels, Cetaphils). It would be interesting to see how its expansion plans pan out in the future(maybe it can produce some winners), but I don't think its going to be a high growth stock in the near future.

I applied quite last minute but wasn't allocated any. For me, I feel HYP is selling "ëstablished products", i.e. the pdts are already on the market for some time, and there is a certain demand for them(e.g. eczema is a common condition) . Furthermore, it is also a net cash company.
You are right to point out the questions on its competitive advantage, for e.g. I don't think its skin care pdts are the most popular ones(compared to the Curels, Cetaphils). It would be interesting to see how its expansion plans pan out in the future(maybe it can produce some winners), but I don't think its going to be a high growth stock in the near future.